Reply: Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial?

Mayra Guerrero; Ted Feldman; William O'Neill

doi:10.1016/j.jcin.2016.10.010

Reply: Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial?

Mayra Guerrero, Ted Feldman, William O'Neill

Cardiovascular Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2461
Number of pages	1
Journal	JACC: Cardiovascular Interventions
Volume	9
Issue number	23
DOIs	https://doi.org/10.1016/j.jcin.2016.10.010
State	Published - Dec 12 2016

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jcin.2016.10.010

Cite this

Reply: Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial? / Guerrero, Mayra; Feldman, Ted; O'Neill, William.
In: JACC: Cardiovascular Interventions, Vol. 9, No. 23, 12.12.2016, p. 2461.

Research output: Contribution to journal › Letter › peer-review

@article{d2c2e79439a44f67881cd3e5bbafb36d,

title = "Reply: Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial?",

author = "Mayra Guerrero and Ted Feldman and William O'Neill",

year = "2016",

month = dec,

day = "12",

doi = "10.1016/j.jcin.2016.10.010",

language = "English (US)",

volume = "9",

pages = "2461",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "23",

}

TY - JOUR

T1 - Reply

T2 - Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial?

AU - Guerrero, Mayra

AU - Feldman, Ted

AU - O'Neill, William

PY - 2016/12/12

Y1 - 2016/12/12

UR - http://www.scopus.com/inward/record.url?scp=85000963037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000963037&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2016.10.010

DO - 10.1016/j.jcin.2016.10.010

M3 - Letter

C2 - 27931601

AN - SCOPUS:85000963037

SN - 1936-8798

VL - 9

SP - 2461

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 23

ER -

Reply: Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this